Katerina Akassoglou and colleagues provide single-cell RNA-sequencing and phosphoproteome analyses of CNS microglia and macrophages in response to blood proteins including activated complement and fibrin. Their findings point to potential therapeutic targeting of microglia activation by immune and vascular signals.
The laboratory of Dr. Katerina Akassoglou developed a method for three-dimensional imaging of neurovascular alterations and blood-brain barrier disruption in cleared human brains. The image shows fibrin (red) around damaged blood vessels (green) and amyloid (blue) in the brain from a patient with Alzheimer’s disease.
Image Credit: Mario Merlini
This honor recognizes ASPET’s most distinguished members for their meritorious efforts to advance pharmacology, through their scientific achievements, mentorship, and service to the Society.
Katerina Akassoglou, PhD received the 2022 ISFP Prize “for outstanding contributions to the field of fibrinolysis and proteolysis” at the 3rd Joint Meeting of the International Society for Fibrinolysis & Proteolysis and the Plasminogen Activation Workshop, held at Caen, France in September, where she delivered the ISFP Prize lecture. Dr. Akassoglou is the first woman to receive the award since its inauguration in 1974.
Andrew Mendiola, received a K99 award from the National Institute of Neurological Disorders and Stroke for his project “Epigenomic regulation of oxidative stress-producing innate immunity in neuroinflammation.”
The purpose of the NIH Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.
Reshmi Tognatta,PhD, has been awarded the AARF for her project “Oligodendroglial-
Vascular Interactions in Alzheimer’s Disease.”
The Alzheimer’s Association Research Fellowship award is intended to support exceptional researchers who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) and working in diverse areas of research, including basic, translational, clinical, functional and social-behavioral research. Investigators doing clinically-focused research without clinical practice are encouraged to apply to this AARF program.
Katerina Akassoglou, PhD, has been elected into the American Association for the Advancement of Science (AAAS), a lifetime distinction by the world’s largest general scientific society.
“I’m grateful to my lab members and collaborators for their immeasurable contributions to these studies over the past 20 years. Election to AAAS further encourages us to follow our curiosity about how brain diseases start and progress and we look forward to new discoveries contributing to the advancement of science.”
Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes, has been named a fellow of the National Academy of Inventors (NAI). Election to NAI is the highest professional distinction given solely to academic inventors.
“Election to the NAI further encourages us to pursue challenging problems in biology and medicine to develop urgently needed treatments for devastating human diseases.”
Dr. Katerina Akassoglou, named one of the Most Influential Women in Bay Area Business. To view the full article, click here.